![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Fresenius Kabi Ipsum S.r.l. Cassina De’ Pecchi It, based in Italy, is a pharmaceutical company.
One of their significant offerings is Ampicillin sodium, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2012-224 - Rev 05
This Chemical Type CEP, issued on February 20, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 578 associated with this CEP further emphasizes